Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Radiation can cause cancer and non-cancer outcomes, but it does not cause every type of cancer and non-cancer outcome.”
RET inhibitor shrank tumors in more than half of people with non-small-cell lung cancer and aggressive thyroid cancer.
HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.
Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men.
A special report on living with cancer
The goal of developing this type of test “is to safely prevent unnecessary surgeries,” said lead investigator Yuri Nikiforov, MD, PhD.
New drug targets RET mutations in multiple cancer types.
This group is more likely to develop several cancers, especially breast cancer, melanoma and non-melanoma skin cancers.
A new therapy, BLU-667, shows broad antitumor activity against cancers with a variety of RET alterations.
Thyroid tumors may be more susceptible to treatment with precisely targeted radiation known as stereotactic body radiation therapy.
LOXO-292 demonstrates durable antitumor activity in people with lung, thyroid and other cancers with RET mutations.
Tafinlar and Mekinist approved for a third cancer with specific gene mutation.
BLU-667 shrinks thyroid and lung cancers with RET gene alterations.
Looking harder for cancer can lead to a self-fulfilling increase in cancer diagnosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.